Global and China Diabetes Therapeutics and Diagnostics Market Size, Status and Forecast 2020-2026

Publication ID:

QYR11201666

Publication Date:

November 23, 2020

Pages:

155

Publisher:

QYR

Region:

Global [1]

$3,900.00

Description:

Global Diabetes Therapeutics and Diagnostics Scope and Market Size
Diabetes Therapeutics and Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diabetes Therapeutics and Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Insulin
Insulin Delivery
Oral Hypoglycemic Drugs
Diagnosis And Monitoring
Others

Market segment by Application, split into
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
Others

Based on regional and country-level analysis, the Diabetes Therapeutics and Diagnostics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Diabetes Therapeutics and Diagnostics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
77 Elektronika Kft.
A. Menarini Diagnostics S.R.L
Abbott Laboratories
Agamatrix Inc.
Animas Corp.
Ascensia
Becton Dickinson
Debiotech S.A.
Eli Lilly And Co.
Glaxo Smithkline
Inlight Solutions Inc.
Johnson & Johnson
Lifescan Inc.
Medtronic
Merck & Co.
Merck KGAA
Nipro Corp.
Novartis Pharma Ag
Novo Nordisk A/S
Owen Mumford Ltd.
Palco Labs Inc.
Roche
Sanofi
Takeda Pharmaceutical Co. Ltd.
Terumo Corp.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Therapeutics and Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Insulin
1.2.3 Insulin Delivery
1.2.4 Oral Hypoglycemic Drugs
1.2.5 Diagnosis And Monitoring
1.2.6 Others
1.3 Market by Application
1.3.1 Global Diabetes Therapeutics and Diagnostics Market Share by Application: 2020 VS 2026
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.3.4 Gestational Diabetes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Diabetes Therapeutics and Diagnostics Market Perspective (2015-2026)
2.2 Global Diabetes Therapeutics and Diagnostics Growth Trends by Regions
2.2.1 Diabetes Therapeutics and Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Diabetes Therapeutics and Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Diabetes Therapeutics and Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Diabetes Therapeutics and Diagnostics Players by Market Size
3.1.1 Global Top Diabetes Therapeutics and Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Players (2015-2020)
3.2 Global Diabetes Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diabetes Therapeutics and Diagnostics Revenue
3.4 Global Diabetes Therapeutics and Diagnostics Market Concentration Ratio
3.4.1 Global Diabetes Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Therapeutics and Diagnostics Revenue in 2019
3.5 Key Players Diabetes Therapeutics and Diagnostics Area Served
3.6 Key Players Diabetes Therapeutics and Diagnostics Product Solution and Service
3.7 Date of Enter into Diabetes Therapeutics and Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Diabetes Therapeutics and Diagnostics Breakdown Data by Type (2015-2026)
4.1 Global Diabetes Therapeutics and Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Diabetes Therapeutics and Diagnostics Forecasted Market Size by Type (2021-2026)

5 Diabetes Therapeutics and Diagnostics Breakdown Data by Application (2015-2026)
5.1 Global Diabetes Therapeutics and Diagnostics Historic Market Size by Application (2015-2020)
5.2 Global Diabetes Therapeutics and Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Diabetes Therapeutics and Diagnostics Market Size (2015-2026)
6.2 North America Diabetes Therapeutics and Diagnostics Market Size by Type (2015-2020)
6.3 North America Diabetes Therapeutics and Diagnostics Market Size by Application (2015-2020)
6.4 North America Diabetes Therapeutics and Diagnostics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada

7 Europe
7.1 Europe Diabetes Therapeutics and Diagnostics Market Size (2015-2026)
7.2 Europe Diabetes Therapeutics and Diagnostics Market Size by Type (2015-2020)
7.3 Europe Diabetes Therapeutics and Diagnostics Market Size by Application (2015-2020)
7.4 Europe Diabetes Therapeutics and Diagnostics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe

8 China
8.1 China Diabetes Therapeutics and Diagnostics Market Size (2015-2026)
8.2 China Diabetes Therapeutics and Diagnostics Market Size by Type (2015-2020)
8.3 China Diabetes Therapeutics and Diagnostics Market Size by Application (2015-2020)
8.4 China Diabetes Therapeutics and Diagnostics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific

9 Japan
9.1 Japan Diabetes Therapeutics and Diagnostics Market Size (2015-2026)
9.2 Japan Diabetes Therapeutics and Diagnostics Market Size by Type (2015-2020)
9.3 Japan Diabetes Therapeutics and Diagnostics Market Size by Application (2015-2020)
9.4 Japan Diabetes Therapeutics and Diagnostics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil

10 Southeast Asia
10.1 Southeast Asia Diabetes Therapeutics and Diagnostics Market Size (2015-2026)
10.2 Southeast Asia Diabetes Therapeutics and Diagnostics Market Size by Type (2015-2020)
10.3 Southeast Asia Diabetes Therapeutics and Diagnostics Market Size by Application (2015-2020)
10.4 Southeast Asia Diabetes Therapeutics and Diagnostics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa

11 Key Players Profiles
11.1 77 Elektronika Kft.
11.1.1 77 Elektronika Kft. Company Details
11.1.2 77 Elektronika Kft. Business Overview
11.1.3 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Introduction
11.1.4 77 Elektronika Kft. Revenue in Diabetes Therapeutics and Diagnostics Business (2015-2020))
11.1.5 77 Elektronika Kft. Recent Development
11.2 A. Menarini Diagnostics S.R.L
11.2.1 A. Menarini Diagnostics S.R.L Company Details
11.2.2 A. Menarini Diagnostics S.R.L Business Overview
11.2.3 A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Introduction
11.2.4 A. Menarini Diagnostics S.R.L Revenue in Diabetes Therapeutics and Diagnostics Business (2015-2020)
11.2.5 A. Menarini Diagnostics S.R.L Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Diabetes Therapeutics and Diagnostics Introduction
11.3.4 Abbott Laboratories Revenue in Diabetes Therapeutics and Diagnostics Business (2015-2020)
11.3.5 Abbott Laboratories Recent Development
11.4 Agamatrix Inc.
11.4.1 Agamatrix Inc. Company Details
11.4.2 Agamatrix Inc. Business Overview
11.4.3 Agamatrix Inc. Diabetes Therapeutics and Diagnostics Introduction
11.4.4 Agamatrix Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2015-2020)
11.4.5 Agamatrix Inc. Recent Development
11.5 Animas Corp.
11.5.1 Animas Corp. Company Details
11.5.2 Animas Corp. Business Overview
11.5.3 Animas Corp. Diabetes Therapeutics and Diagnostics Introduction
11.5.4 Animas Corp. Revenue in Diabetes Therapeutics and Diagnostics Business (2015-2020)
11.5.5 Animas Corp. Recent Development
11.6 Ascensia
11.6.1 Ascensia Company Details
11.6.2 Ascensia Business Overview
11.6.3 Ascensia Diabetes Therapeutics and Diagnostics Introduction
11.6.4 Ascensia Revenue in Diabetes Therapeutics and Diagnostics Business (2015-2020)
11.6.5 Ascensia Recent Development
11.7 Becton Dickinson
11.7.1 Becton Dickinson Company Details
11.7.2 Becton Dickinson Business Overview
11.7.3 Becton Dickinson Diabetes Therapeutics and Diagnostics Introduction
11.7.4 Becton Dickinson Revenue in Diabetes Therapeutics and Diagnostics Business (2015-2020)
11.7.5 Becton Dickinson Recent Development
11.8 Debiotech S.A.
11.8.1 Debiotech S.A. Company Details
11.8.2 Debiotech S.A. Business Overview
11.8.3 Debiotech S.A. Diabetes Therapeutics and Diagnostics Introduction
11.8.4 Debiotech S.A. Revenue in Diabetes Therapeutics and Diagnostics Business (2015-2020)
11.8.5 Debiotech S.A. Recent Development
11.9 Eli Lilly And Co.
11.9.1 Eli Lilly And Co. Company Details
11.9.2 Eli Lilly And Co. Business Overview
11.9.3 Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Introduction
11.9.4 Eli Lilly And Co. Revenue in Diabetes Therapeutics and Diagnostics Business (2015-2020)
11.9.5 Eli Lilly And Co. Recent Development
11.10 Glaxo Smithkline
11.10.1 Glaxo Smithkline Company Details
11.10.2 Glaxo Smithkline Business Overview
11.10.3 Glaxo Smithkline Diabetes Therapeutics and Diagnostics Introduction
11.10.4 Glaxo Smithkline Revenue in Diabetes Therapeutics and Diagnostics Business (2015-2020)
11.10.5 Glaxo Smithkline Recent Development
11.11 Inlight Solutions Inc.
10.11.1 Inlight Solutions Inc. Company Details
10.11.2 Inlight Solutions Inc. Business Overview
10.11.3 Inlight Solutions Inc. Diabetes Therapeutics and Diagnostics Introduction
10.11.4 Inlight Solutions Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2015-2020)
10.11.5 Inlight Solutions Inc. Recent Development
11.12 Johnson & Johnson
10.12.1 Johnson & Johnson Company Details
10.12.2 Johnson & Johnson Business Overview
10.12.3 Johnson & Johnson Diabetes Therapeutics and Diagnostics Introduction
10.12.4 Johnson & Johnson Revenue in Diabetes Therapeutics and Diagnostics Business (2015-2020)
10.12.5 Johnson & Johnson Recent Development
11.13 Lifescan Inc.
10.13.1 Lifescan Inc. Company Details
10.13.2 Lifescan Inc. Business Overview
10.13.3 Lifescan Inc. Diabetes Therapeutics and Diagnostics Introduction
10.13.4 Lifescan Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2015-2020)
10.13.5 Lifescan Inc. Recent Development
11.14 Medtronic
10.14.1 Medtronic Company Details
10.14.2 Medtronic Business Overview
10.14.3 Medtronic Diabetes Therapeutics and Diagnostics Introduction
10.14.4 Medtronic Revenue in Diabetes Therapeutics and Diagnostics Business (2015-2020)
10.14.5 Medtronic Recent Development
11.15 Merck & Co.
10.15.1 Merck & Co. Company Details
10.15.2 Merck & Co. Business Overview
10.15.3 Merck & Co. Diabetes Therapeutics and Diagnostics Introduction
10.15.4 Merck & Co. Revenue in Diabetes Therapeutics and Diagnostics Business (2015-2020)
10.15.5 Merck & Co. Recent Development
11.16 Merck KGAA
10.16.1 Merck KGAA Company Details
10.16.2 Merck KGAA Business Overview
10.16.3 Merck KGAA Diabetes Therapeutics and Diagnostics Introduction
10.16.4 Merck KGAA Revenue in Diabetes Therapeutics and Diagnostics Business (2015-2020)
10.16.5 Merck KGAA Recent Development
11.17 Nipro Corp.
10.17.1 Nipro Corp. Company Details
10.17.2 Nipro Corp. Business Overview
10.17.3 Nipro Corp. Diabetes Therapeutics and Diagnostics Introduction
10.17.4 Nipro Corp. Revenue in Diabetes Therapeutics and Diagnostics Business (2015-2020)
10.17.5 Nipro Corp. Recent Development
11.18 Novartis Pharma Ag
10.18.1 Novartis Pharma Ag Company Details
10.18.2 Novartis Pharma Ag Business Overview
10.18.3 Novartis Pharma Ag Diabetes Therapeutics and Diagnostics Introduction
10.18.4 Novartis Pharma Ag Revenue in Diabetes Therapeutics and Diagnostics Business (2015-2020)
10.18.5 Novartis Pharma Ag Recent Development
11.19 Novo Nordisk A/S
10.19.1 Novo Nordisk A/S Company Details
10.19.2 Novo Nordisk A/S Business Overview
10.19.3 Novo Nordisk A/S Diabetes Therapeutics and Diagnostics Introduction
10.19.4 Novo Nordisk A/S Revenue in Diabetes Therapeutics and Diagnostics Business (2015-2020)
10.19.5 Novo Nordisk A/S Recent Development
11.20 Owen Mumford Ltd.
10.20.1 Owen Mumford Ltd. Company Details
10.20.2 Owen Mumford Ltd. Business Overview
10.20.3 Owen Mumford Ltd. Diabetes Therapeutics and Diagnostics Introduction
10.20.4 Owen Mumford Ltd. Revenue in Diabetes Therapeutics and Diagnostics Business (2015-2020)
10.20.5 Owen Mumford Ltd. Recent Development
11.21 Palco Labs Inc.
10.21.1 Palco Labs Inc. Company Details
10.21.2 Palco Labs Inc. Business Overview
10.21.3 Palco Labs Inc. Diabetes Therapeutics and Diagnostics Introduction
10.21.4 Palco Labs Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2015-2020)
10.21.5 Palco Labs Inc. Recent Development
11.22 Roche
10.22.1 Roche Company Details
10.22.2 Roche Business Overview
10.22.3 Roche Diabetes Therapeutics and Diagnostics Introduction
10.22.4 Roche Revenue in Diabetes Therapeutics and Diagnostics Business (2015-2020)
10.22.5 Roche Recent Development
11.23 Sanofi
10.23.1 Sanofi Company Details
10.23.2 Sanofi Business Overview
10.23.3 Sanofi Diabetes Therapeutics and Diagnostics Introduction
10.23.4 Sanofi Revenue in Diabetes Therapeutics and Diagnostics Business (2015-2020)
10.23.5 Sanofi Recent Development
11.24 Takeda Pharmaceutical Co. Ltd.
10.24.1 Takeda Pharmaceutical Co. Ltd. Company Details
10.24.2 Takeda Pharmaceutical Co. Ltd. Business Overview
10.24.3 Takeda Pharmaceutical Co. Ltd. Diabetes Therapeutics and Diagnostics Introduction
10.24.4 Takeda Pharmaceutical Co. Ltd. Revenue in Diabetes Therapeutics and Diagnostics Business (2015-2020)
10.24.5 Takeda Pharmaceutical Co. Ltd. Recent Development
11.25 Terumo Corp.
10.25.1 Terumo Corp. Company Details
10.25.2 Terumo Corp. Business Overview
10.25.3 Terumo Corp. Diabetes Therapeutics and Diagnostics Introduction
10.25.4 Terumo Corp. Revenue in Diabetes Therapeutics and Diagnostics Business (2015-2020)
10.25.5 Terumo Corp. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

77 Elektronika Kft.
A. Menarini Diagnostics S.R.L
Abbott Laboratories
Agamatrix Inc.
Animas Corp.
Ascensia
Becton Dickinson
Debiotech S.A.
Eli Lilly And Co.
Glaxo Smithkline
Inlight Solutions Inc.
Johnson & Johnson
Lifescan Inc.
Medtronic
Merck & Co.
Merck KGAA
Nipro Corp.
Novartis Pharma Ag
Novo Nordisk A/S
Owen Mumford Ltd.
Palco Labs Inc.
Roche
Sanofi
Takeda Pharmaceutical Co. Ltd.
Terumo Corp.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.